Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Natural Health Trends (NHTC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Natural Health Trends (NHTC) over the last 16 years, with Q3 2025 value amounting to $2.5 million.

  • Natural Health Trends' Cost of Revenue fell 994.58% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year decrease of 432.6%. This contributed to the annual value of $11.2 million for FY2024, which is 2.68% up from last year.
  • Per Natural Health Trends' latest filing, its Cost of Revenue stood at $2.5 million for Q3 2025, which was down 994.58% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Natural Health Trends' Cost of Revenue registered a high of $4.2 million during Q4 2021, and its lowest value of $2.5 million during Q3 2025.
  • In the last 5 years, Natural Health Trends' Cost of Revenue had a median value of $2.9 million in 2022 and averaged $3.0 million.
  • In the last 5 years, Natural Health Trends' Cost of Revenue crashed by 2789.1% in 2021 and then soared by 422.97% in 2023.
  • Over the past 5 years, Natural Health Trends' Cost of Revenue (Quarter) stood at $4.2 million in 2021, then fell by 21.43% to $3.3 million in 2022, then fell by 14.53% to $2.8 million in 2023, then increased by 0.47% to $2.8 million in 2024, then decreased by 11.13% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $2.6 million for Q2 2025, and $2.8 million during Q1 2025.